カテゴリ： MarketLine, イギリス, 企業調査

Standard Chartered Plc：企業の戦略・SWOT・財務情報

◆英語タイトル：Standard Chartered Plc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C3954
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：60
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Standard Chartered Plc – Strategy, SWOT and Corporate Finance Report
Summary

Standard Chartered Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Standard Chartered PLC (Standard Chartered) is a global financial institution. The company provides a range of products and services in the fields of personal banking, wholesale banking, private banking, SME banking, and business banking. Its portfolio of products includes savings accounts, current accounts, fixed deposits, term deposits, credit cards, debit cards, personal loans, home loans, corporate loans, mortgages, investment products, life insurance, health and medical insurance, home insurance, and motor insurance. The company offers services such as transactional banking services, mergers and acquisitions advisory services, investment advisory services, wealth management services, Islamic banking services, private banking services, and e-banking services. It serves its customers through a network of branches and outlets across the globe. Standard Chartered is headquartered in London, the UK.

Scope

- Detailed information on Standard Chartered Plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Standard Chartered Plc in the form of a SWOT analysis
- An in-depth view of the business model of Standard Chartered Plc including a breakdown and examination of key business segments
- Intelligence on Standard Chartered Plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Standard Chartered Plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Standard Chartered Plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Standard Chartered Plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Standard Chartered Plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Standard Chartered Plc: Company Overview 9
Standard Chartered Plc: Overview and Key Facts 9
Standard Chartered Plc: Overview 9
Standard Chartered Plc: Key Facts 9
Standard Chartered Plc: Key Employees 11
Standard Chartered Plc: Key Employee Biographies 14
Standard Chartered Plc: Major Products and Services 17
Standard Chartered Plc: Company History 18
Standard Chartered Plc: Management Statement 25
Standard Chartered Plc: Locations and Subsidiaries 29
Standard Chartered Plc: Key Competitors 33
Standard Chartered Plc: Company Analysis 34
Standard Chartered Plc: Business Description 34
Standard Chartered Plc: SWOT Analysis 35
Standard Chartered Plc: SWOT Overview 35
Standard Chartered Plc: Strengths 35
Standard Chartered Plc: Weaknesses 36
Standard Chartered Plc: Opportunities 36
Standard Chartered Plc: Threats 37
Standard Chartered Plc: Corporate Financial Deals Activity 39
Standard Chartered Plc: Financial Deals Overview 39
Standard Chartered Plc: Targets and Partners 41
Standard Chartered Plc: Top Deals 2014 – 2018YTD* 42
Standard Chartered Plc: Advisors 43
Standard Chartered Plc: Top Legal Advisors 43
Standard Chartered Plc: Top Financial Advisors 43
Standard Chartered Plc: Mergers and Acquisitions 45
Standard Chartered Plc: Corporate Venturing 46
Standard Chartered Plc: Capital Raising 47
Standard Chartered Plc: Partnership 48
Standard Chartered Plc: Divestments 49
Standard Chartered Plc: Recent Developments 50
Standard Chartered Plc: News and Events Summary 50
Standard Chartered Plc: Contracts 53
Standard Chartered Plc: Corporate Governance 55
Standard Chartered Plc: Financial Deals 55
Standard Chartered Plc: Financial Performance 56
Standard Chartered Plc: Regulatory and Legal Events 56
Standard Chartered Plc: Strategy and Operations 57
Appendix 58
Contact Us 58
Methodology 58
About MarketLine 59

List of Tables
Table 1: Standard Chartered Plc: Key Facts
Table 2: Standard Chartered Plc: Key Employees
Table 3: Standard Chartered Plc: Locations and Subsidiaries
Table 4: Standard Chartered Plc: Key Competitors
Table 5: Standard Chartered Plc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Standard Chartered Plc: M&A Activity by Geography (TTM*)
Table 7: Standard Chartered Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Standard Chartered Plc: M&A Average Deal Size - Value (US$m)
Table 9: Standard Chartered Plc: Targets and Partners
Table 10: Standard Chartered Plc: Top Deals 2014 - 2018YTD*
Table 11: Standard Chartered Plc: Legal Advisor Ranking by Value (US$m)
Table 12: Standard Chartered Plc: Financial Advisor Ranking by Value (US$m)
Table 13: Standard Chartered Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Standard Chartered Plc: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Standard Chartered Plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Standard Chartered Plc: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Standard Chartered Plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: Standard Chartered Plc: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: Standard Chartered Plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: Standard Chartered Plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: Standard Chartered Plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 22: Standard Chartered Plc: News and Events Summary
Table 23: Standard Chartered Plc: Contracts
Table 24: Standard Chartered Plc: Corporate Governance
Table 25: Standard Chartered Plc: Financial Deals
Table 26: Standard Chartered Plc: Financial Performance
Table 27: Standard Chartered Plc: Regulatory and Legal Events
Table 28: Standard Chartered Plc: Strategy and Operations

List of Figures
Figure 1: Standard Chartered Plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Standard Chartered Plc: M&A Activity by Geography (TTM*)
Figure 3: Standard Chartered Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Standard Chartered Plc: M&A Average Deal Size - Value (US$m)
Figure 5: Standard Chartered Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Standard Chartered Plc: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Standard Chartered Plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Standard Chartered Plc: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Standard Chartered Plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: Standard Chartered Plc: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: Standard Chartered Plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Standard Chartered Plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: Standard Chartered Plc: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Standard Chartered Plc：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Intraco Ltd (I06)：企業の財務・戦略的SWOT分析
    Intraco Ltd (I06) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Covalon Technologies Ltd (COV)-製薬・医療分野：企業M&A・提携分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercialization of medical devices and healthcare technologies. The company offers advanced wound solutions, infection prevention products and perioperative care products. Covalon offers wound care products such as collagen …
  • Exiqon AS-医療機器分野：企業M&A・提携分析
    Summary Exiqon A/S (Exiqon), a subsidiary of Qiagen NV is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company’s product categories include microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reagent pro …
  • OpenHydro Group Limited-エネルギー分野：企業M&A・提携分析
    Summary OpenHydro Group Limited (OpenHydro), a subsidiary of DCNS S.A. designs and manufactures marine turbines for generating renewable energy from tidal streams. The company offers installation and maintenance services for the construction of tidal farms using its Open-Centre Turbine technology. T …
  • Corbion NV：企業のM&A・事業提携・投資動向
    Corbion NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Corbion NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • National Railroad Passenger Corporation：企業の戦略・SWOT・財務情報
    National Railroad Passenger Corporation - Strategy, SWOT and Corporate Finance Report Summary National Railroad Passenger Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Mereo Biopharma Group Plc (MPH)：製薬・医療：M&Aディール及び事業提携情報
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • New York City Health and Hospitals Corp：企業の戦略的SWOT分析
    New York City Health and Hospitals Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Jack Henry & Associates, Inc.：企業の戦略・SWOT・財務情報
    Jack Henry & Associates, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jack Henry & Associates, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Stellar Resources Ltd：企業の戦略・SWOT・財務分析
    Stellar Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Stellar Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • MDU Resources Group Inc (MDU)：企業の財務・戦略的SWOT分析
    MDU Resources Group Inc (MDU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Arena Pharmaceuticals Inc (ARNA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Arena Pharmaceuticals Inc (Arena) is a biopharmaceutical company which discovers, develops and commercializes small molecule drugs in multiple therapy areas. It is evaluating its lead candidate etrasimod for multiple inflammatory indications including ulcerative colitis, primary biliary chol …
  • CRH Plc (CRH)：企業の財務・戦略的SWOT分析
    CRH Plc (CRH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Helix Energy Solutions Group, Inc.：企業の戦略・SWOT・財務分析
    Helix Energy Solutions Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Helix Energy Solutions Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Mega First Corporation Bhd (MFCB)：企業の財務・戦略的SWOT分析
    Summary Mega First Corporation Bhd (MFCB) is a diversified company. The company operates through its business divisions such as power generation, resources, and property development and investment. Its power generation business builds, owns, operates and maintains coal-fired heat and power plant. MF …
  • TKH Group NV (TWEKA)：企業の財務・戦略的SWOT分析
    TKH Group NV (TWEKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • AngioChem Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary AngioChem Inc (AngioChem) is a clinical-stage biotechnology company that discovers and develops new drugs to treat brain related disorders. The company’s products comprise oncology products, peptide antibody conjugates, antibody-drug conjugates, pain products and lysosomal storage diseases p …
  • Jcb Co., Ltd.
    Jcb Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Jcb Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Republic Services, Inc.：戦略・SWOT・企業財務分析
    Republic Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Republic Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Intrexon Corp (XON)：企業の財務・戦略的SWOT分析
    Summary Intrexon Corp (Intrexon), formerly Genomatix Corp is a synthetic biology service provider. The company operates through its divisions and units such as cell engineering, data sciences and computational biology, information technology (IT), actobiotics, molecular engineering, agricultural bio …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆